Sapience Therapeutics, Inc.

Below is Scrip ’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Unite

Kite Pharma Inc. recently told investors that it's on the cusp of producing late-stage data that could enable a filing of its lead cancer immunotherapy candidate, KTE-C19, but the biotech also recen

Alcresta Inc. Alcresta brings in $49.4m via Series C Alcresta Inc. (therapies for gastrointestinal disorders and rare diseases) raised $49.4m in its Series C financing to new backer Athyrium a

US venture capital investment in biotechnology companies fell during the second quarter, but remained near recent record-breaking levels as investors continued to support larger funding rounds for som